Back to results
US 5,589,168 AGranted
Probiotic
AssigneeUnilever Patent Holdings B.V.
InventorsWilliam D. Allen, Margaret A. Linggood, Philip Porter
Life of this patent
Estimating the term…
Abstract
A novel strain of Enterococcus faecium, deposited as NCIMB 40371, has valuable probiotic properties and is particularly effective in alleviating symptoms of irritable bowel syndrome in human patients. The novel strain can be used in the manufacture of human foodstuffs.
Claims4
Organisms of Enterococcus faecium selected from the group consisting of strain NCIMB 40371 and IBS-alleviating mutants thereof.
Enterococcus faecium strain NCIMB 40371.
Dependencies are inferred from the claim text.